Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add? [electronic resource]
Producer: 20200907Description: 1466-1471 p. digitalISSN:- 1522-9645
- Aspirin -- adverse effects
- Atherosclerosis -- complications
- Chronic Disease
- Clinical Trials as Topic
- Death
- Drug Therapy, Combination
- Factor Xa Inhibitors -- adverse effects
- Fibrinolytic Agents -- adverse effects
- Hemorrhage -- chemically induced
- Humans
- Myocardial Infarction -- epidemiology
- Platelet Aggregation Inhibitors -- adverse effects
- Rivaroxaban -- adverse effects
- Secondary Prevention -- methods
- Stroke -- epidemiology
- Thrombosis -- prevention & control
- Vascular Diseases -- pathology
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.